LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer
NCT01485744
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
39
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer
Interventions
DRUG:
LDE225; Fluorouracil; Leucovorin; Oxaliplatin; Irinotecan
Sponsor
Massachusetts General Hospital
Collaborators
[object Object]